van der Bruggen P - Search Results

1

Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient.

Abad S, Wieërs G, Colau D, Wildmann C, Delair E, Dhote R, Brézin AP, Kawakami Y, Coulie PG, van der Bruggen P. Abad S, et al. Among authors: van der bruggen p. Mol Vis. 2014 Jul 2;20:956-69. eCollection 2014. Mol Vis. 2014. PMID: 24991188 Free PMC article.

2

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

van der Bruggen P, Szikora JP, Boël P, Wildmann C, Somville M, Sensi M, Boon T. van der Bruggen P, et al. Eur J Immunol. 1994 Sep;24(9):2134-40. doi: 10.1002/eji.1830240930. Eur J Immunol. 1994. PMID: 7522162

3

Genes coding for tumor antigens recognized by cytolytic T lymphocytes.

Van Pel A, van der Bruggen P, Coulie PG, Brichard VG, Lethé B, van den Eynde B, Uyttenhove C, Renauld JC, Boon T. Van Pel A, et al. Among authors: van den eynde b, van der bruggen p. Immunol Rev. 1995 Jun;145:229-50. doi: 10.1111/j.1600-065x.1995.tb00084.x. Immunol Rev. 1995. PMID: 7590828 Review. No abstract available.

4

A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3.

van der Bruggen P, Bastin J, Gajewski T, Coulie PG, Boël P, De Smet C, Traversari C, Townsend A, Boon T. van der Bruggen P, et al. Eur J Immunol. 1994 Dec;24(12):3038-43. doi: 10.1002/eji.1830241218. Eur J Immunol. 1994. PMID: 7805731

5

BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes.

Boël P, Wildmann C, Sensi ML, Brasseur R, Renauld JC, Coulie P, Boon T, van der Bruggen P. Boël P, et al. Among authors: van der bruggen p. Immunity. 1995 Feb;2(2):167-75. doi: 10.1016/s1074-7613(95)80053-0. Immunity. 1995. PMID: 7895173 Free article.

6

Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1.

Marchand M, Brasseur F, van der Bruggen P, Coulie P, Boon T. Marchand M, et al. Among authors: van der bruggen p. Dermatology. 1993;186(4):278-80. doi: 10.1159/000247375. Dermatology. 1993. PMID: 8513199

7

Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.

Van den Eynde B, Gaugler B, van der Bruggen P, Coulie P, Brichard V, Boon T. Van den Eynde B, et al. Among authors: van der bruggen p. Biochem Soc Trans. 1995 Aug;23(3):681-6. doi: 10.1042/bst0230681. Biochem Soc Trans. 1995. PMID: 8566443 Review. No abstract available.

8

A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3.

Herman J, van der Bruggen P, Luescher IF, Mandruzzato S, Romero P, Thonnard J, Fleischhauer K, Boon T, Coulie PG. Herman J, et al. Among authors: van der bruggen p. Immunogenetics. 1996;43(6):377-83. doi: 10.1007/BF02199806. Immunogenetics. 1996. PMID: 8606058

9

Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes.

De Plaen E, Lurquin C, Lethé B, van der Bruggen P, Brichard V, Renauld JC, Coulie P, Van Pel A, Boon T. De Plaen E, et al. Among authors: van pel a, van der bruggen p. Methods. 1997 Jun;12(2):125-42. doi: 10.1006/meth.1997.0462. Methods. 1997. PMID: 9184377 Review.

10

Antigens recognized by T-lymphocytes on human tumours.

Coulie PG, Van den Eynde BJ, van der Bruggen P, Van Pel A, Boon T. Coulie PG, et al. Among authors: van pel a, van den eynde bj, van der bruggen p. Biochem Soc Trans. 1997 May;25(2):544-8. doi: 10.1042/bst0250544. Biochem Soc Trans. 1997. PMID: 9191153 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters